Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 9, 2005

View Archived Issues

Nalfurafine hydrochloride reduces scratching in a possible murine model of pruritis

Recent patents cover novel treatments for neurodegenerative disorders

New treatments for psychosis and depression in early development

Novel diagnostic agents disclosed by Amersham

MMP inhibitors for arthritis emerge from Japan Tobacco R&D

CYC-10268 targets macrophage survival in vitro

ELB-353: in vitro and in vivo data demonstrate potential for asthma/COPD

MEK1 inhibitor achieves superior results in a murine colon cancer model

TTI-237: A novel, small-molecule tubulin inhibitor with novel mechanism of action

Mycophenolate mofetil shows promise in the treatment of inflammatory eye disease

Gentium updates status of defibrotide program

Enrollment completed in phase II study of MN-001 for asthma

Phase III Veronate trial recommended to continue by DSMB

Novartis and Alnylam establish major RNAi alliance

Avax files IND for phase I/II NSCLC study of AC Vaccine Therapeutic

ACTIVE W arm discontinued in clopidogrel program

Centocor selects new target in Morphosys collaboration

huN901-DM1 enters clinical testing for multiple myeloma

Celera Diagnostics and Merck & Co extend Alzheimer's collaboration

Genentech targets Lucentis BLA filing for December

WHO urges monitoring of antimalarials for effectiveness

Ataciguat - a promising therapeutic option for cardiovascular complications in diabetic patients

In vivo models validate superior efficacy of BAY-59-7939 over fondaparinux

AVE-0118 is safe in experimental CHF

Novel pathway-selective LXR modulator developed

Novel HCV-NS3 protease inhibitor enters clinical development

Preclinical studies evaluate the antinociceptive effects of TQ-1015

Dronedarone reduces the ventricular rate of patients with atrial fibrillation

AZD-6140 shows efficacy in inhibiting platelet aggregation in patients with atherosclerosis

Swiss approval for once-monthly Bonviva

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...